+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Acorda Therapeutics Inc - logo

Acorda Therapeutics is a biopharmaceutical company that identifies, develops, and commercializes novel therapies for neurological disorders in the United States. It specializes in drugs that improve neurological function in people with multiple sclerosis, spinal cord injury and other disorders of the central nervous system. Its best known products are Zanaflex, Ampyra and Qutenza. Acorda Therapeutics was founded in 1995 and is headquartered in Ardsley, New York.

Cerebral Palsy Global Clinical Trials Review, H2, 2018 - Product Thumbnail Image

Cerebral Palsy Global Clinical Trials Review, H2, 2018

  • Clinical Trials
  • December 2018
  • 154 Pages
From
Acute Spinal Cord Injury Global Clinical Trials Review, H2, 2018 - Product Thumbnail Image

Acute Spinal Cord Injury Global Clinical Trials Review, H2, 2018

  • Clinical Trials
  • October 2018
  • 64 Pages
From
From
From
Optic Neuropathy Global Clinical Trials Review, H1, 2018 - Product Thumbnail Image

Optic Neuropathy Global Clinical Trials Review, H1, 2018

  • Clinical Trials
  • April 2018
  • 59 Pages
From
From
From
Muscle Spasticity Global Clinical Trials Review, H1, 2018 - Product Thumbnail Image

Muscle Spasticity Global Clinical Trials Review, H1, 2018

  • Clinical Trials
  • March 2018
  • 171 Pages
From
From
Parkinson's: Epidemiology Overview and Insights - Product Thumbnail Image

Parkinson's: Epidemiology Overview and Insights

  • Report
  • April 2018
  • 50 Pages
From
From
Inbrija - Product Thumbnail Image

Inbrija

  • Report
  • June 2018
  • 15 Pages
From
From
From
From
Bladder Pain - Pipeline Insight, 2020 - Product Thumbnail Image

Bladder Pain - Pipeline Insight, 2020

  • Drug Pipelines
  • February 2020
  • 106 Pages
From
From
From
Loading Indicator
adroll